Insys Therapeutics revenue

Insys Therapeutics revenue decreased from $140.7 million in 2017 to $82.1 million in 2018, a 41.7% decrease.

Annual Revenue ($)

Insys Therapeutics revenue was $82.08 m in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$99.29 m$222.13 m$330.80 m$242.28 m$140.69 m$82.08 m
Growth123.72%48.92%(26.76%)
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019
Revenue$29.21 m$41.64 m$55.70 m$58.28 m$70.77 m$77.63 m$91.26 m$61.96 m$67.12 m$55.18 m$35.96 m$42.58 m$30.67 m$23.91 m$23.47 m$18.35 m$7.63 m

Annual Growth Rate (%)